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Abstract. Recent studies suggest that a cycle of acyla-
tion/deacylation is involved in the vesicular transport
of proteins between intracellular compartments at both
the budding and the fusion stage (Glick, B. S., and
J. E. Rothman. 1987. Nature (Lond.). 326:309-312) .
Since a number of cellular processes requiring vesicu-
lar transport are inhibited during mitosis, we exam-
ined the fatty acylation of proteins in interphase and
mitotic cells. We have identified a major palmitoylated
protein with an apparent molecular weight of 62,000
(p62), whose level of acylation increases 5-10-fold
during mitosis. Acylation was reversible and p62 was
no longer palmitoylated in cells that have exited mito-
sis and entered G1. p62 is tightly bound to the cyto-
plasmic side of membranes, since it was sensitive to
digestion with proteases in the absence of detergent
and was not removed by treatment with 1 M KCI. p62
is removed from membranes by nonionic detergents or
substantial number of proteins of both cellular and
viral origin contain long-chain fattyacids covalently
L
￿
IL bound to the polypeptide backbone (McIlhinney,
1990). However, the functional consequences of this post-
translational modification are unknown. There are two major
classes of acyl proteins. One class contains the 14-carbon
saturated fatty acid, myristate, which is added co-transla-
tionally and remains stably bound throughoutthe lifetime of
the protein. The second class ofproteins contains the 16-car-
bon saturated fattyacid, palmitate, and is modified posttrans-
lationally. In most cases, palmitic acid appears to be linked
via thioester bonds to internal cysteines (Olson, 1988) al-
though O-esterlinkages may also occur(Ding and Trowbridge,
1990). Palmitoylated proteins fall into two categories de-
pending on whether the palmitoyl group undergoes turnover
or not. Viral glycoproteins are the best studied example of
irreversibly palmitoylated proteins. The viral glycoproteins
are acylated shortly after synthesis in a compartment that re-
sides between the ER and the cis-Golgi (Bonatti et al ., 1989)
and do not appear to undergo reversible acylation because
inhibitors of protein synthesis block palmitoylation of these
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concentrations of urea >4 M. The localization of p62
by subcellular fractionation is consistent with it being
in the cis-Golgi or the cis-Golgi network. A palmitoy-
lated protein of the same molecular weight was also
observed in interphase cells treated with inhibitors of
intracellular transport, such as brefeldin A, monensin,
carbonylcyanide m-chlorophenylhydrazone, or alumi-
num fluoride. The protein palmitoylated in the pres-
ence of brefeldin A was shown to be the same as that
palmitoylated during mitosis using partial proteolysis.
Digestion with two enzymes, alkaline protease and en-
doprotease lys-C, generated the same 3H-palmitate-
labeled peptide fragments from p62 from mitotic or
brefeldin A-treated cells. We suggest that the acylation
and deacylation of p62 may be important in vesicular
transport and that this process may be regulated
during mitosis.
proteins. However, Olson and Spizz (1986) have demon-
strated that <1% of the pahnitoylated proteins in BC3H1
muscle cellsare transmembrane glycoproteins. The majority
ofthe palmitoylated proteins in cells do not contain carbohy-
drate and are acylated by a mechanism that is independent
ofprotein synthesis. The reversible fatty acylation of several
pahnitoylated proteins has been demonstrated in vivo, in-
cluding the transferrin receptor, p21"-, the neuronal growth
cone protein GAP-43, several erythrocyte cytoskeletal pro-
teins, and p64, a protein which is deacylated in response to
growth factor stimulation (Omary and Trowbridge, 1981;
Magee et al ., 1987; Staufenbiel, 1988; Skene and Virag,
1989; James and Olson, 1989). Palmitoylation may deter-
mine the extent to which a protein is associated with mem-
branes, but many pahnitoylated proteins are now known to
associate independently of fatty acylation (Hancock et al.,
1989). The role of covalently bound fattyacids may therefore
bemore complex than simply serving as a hydrophobic mem-
brane anchor.
Recent reports have suggested a role for fatty acylation in
intracellular transport (Glick and Rothman, 1987) . The
mechanism of vesicle mediated transport is thought to be the
same from the ER to the Golgi complex and through the Gol-
gi stack up to the trans-Golgi network (see Warren, 1990) .
135Transport from the cis-to-medial cisternae has been particu-
larly well characterized (Rothman and Orci, 1990), and pal-
mitoyl-CoA is thought to be required for both the budding
of transport vesicles (Glick and Rothman, 1987; Pfanner et
al., 1989) and for subsequent fusion with the next cistema
(Pfanner et al., 1990). Membrane fusion requiresthe recruit-
ment of several proteins from the cytosol to the membrane
to form a complex which can catalyze the fusion reaction
(Rothman and Orci, 1990). Reversible palmitoylation ofone
or more of the proteins in such a complex has been proposed
as a possible mechanism that would allow rapid recycling of
transport components. The palmitoylation target has not,
however, been identified.
One approach to identifying possible target proteins is to
exploit inhibitors of intracellular transport. In mammalian
cells membrane traffic is inhibited during mitosis. This in-
cludes endocytosis, exocytosis, and receptor recycling (War-
ren, 1985). In addition, neither newly synthesized proteins
(Featherstone et al., 1985) nor glycolipids (Kobayashi and
Pagano, 1989) are transported through the secretory pathway
to the cell surface. In fact, all vesicle-mediated traffic ap-
pears to be inhibited. By comparing the palmitoylation pat-
terns between interphase and mitotic cellswe have identified
a major palmitoylated protein (p62) which is only clearly de-
tected during mitosis. The same protein becomes acylated in
cellstreatedwith the intracellular transport inhibitors brefel-
din A (BFA)', monensin, carbonylcyanide m-chlorophenyl-
hydrazone (CCCP), and aluminum fluoride, suggesting that




Cell culture media were purchased fromNorthumbriaBiological Laborato-
ries (Northumbria, UK). 3H-palmitate (60 Ci/mmol) was purchased from
New England Nuclear (Boston, MA). BFA was purchased from Epicenter
Technologies (Madison, WI) and stored according to the manufacturer's in-
structions. All other chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO), BDH Chemicals Ltd. (Dagenham, Essex, England), or
Boehringer-Mannheim Diagnostics, Inc. (Houston, TX) unless otherwise
stated.
Cells
The 15B clone of CHO cells (Gottlieb et al., 1974) were maintained as
monolayers in a-MEM containing 10% FCS, 100 U/ml penicillin-strep-
tomycin, 2 mM glutamine, and non essential amino acids. Other cells were
maintained as follows: normal rat kidney (Louvard et al., 1982), A431
(Woodman and Warren, 1988), HeLa (Lucocq et al., 1987), and BHK
(Green et al ., 1981).
Mitotic Cells
Mitotic 15B cells were prepared essentially as described by Balch et al.
(1987) except that cells were grown to confluency in 850-cm2 roller bot-
tles. After incubation with nocodazole (100 ng/ml) for 3 h, mitotic cells
were selectively removed from the monolayer by spinning the roller bottle
at 300 rpm for 3 min at 37°C using a modified roller apparatus (Klevecz,
1975). This method yielded N5-8 x 107 cellsholler bottle with a mitotic
index of 94-98% as judged by staining with Hoechst dye 33258. Mitotic
cells had to be labeled and used within 5-6 h of exposure to nocodazole
or the cells would begin to exit mitosis spontaneously.
1. Abbreviations used in this paper: BFA, brefeldin A; CCCP, carbonyl-
cyanide m-chlorophenylhydrazone.
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Labelingwith 3H-Phlmitate
Interphase cells, grown in 60-mm culture dishes, were washed three times
with serum-free growth medium and usually labeled in MEM buffered with
20 mM Hepes, pH 7.4, containing 7.5% FCS and 50 pCi/ml 3H-palmitate.
The FCS was filtered through a 0.2-pm nitrocellulose filter before use. Mi-
totic cells were labeled in suspension and maintained in the mitotic state
by including 100 ng/ml of nocodazole. Cells were incubated at 37°C for
60-90 min as indicated in the figure legends. Monolayers were released
using either trypsin/EDTA or Tris/salt (25 mM Tris-HCI, pH 7.4, 137 mM
NaCl, 5 mM KCI, and 1 mM Na2HPO4) containing 5 mM EDTA. Cells
were pelleted at low speed and washed once with Dulbeccds PBS. The cell
pellets were then extracted for at least 1 h on ice with 200 Al 1% Triton
X-100 in Dulbeccds PBS containing 1 mM EGTA, 1 mM EDTA, 10 mg/ml
soy bean trypsin inhibitor, 1 mM iodoacetamide, and 10 pg/ml each of
chymostatin, leupeptin, antipain, and pepstatin. The nuclei were removed
by centrifugation in an Eppendorfmicrocentrifuge (Brinkman Instruments
Co., Westbury NY) at 14,000 rpm for 30 s at room temperature. Protein
was determined by the BCA method (Pierce Chemical Co., Rockford, IL),
using BSA as a standard and equal amounts ofprotein were precipitated by
the method of Wessel and Flugge (1984). The precipitates were solubilized
in Laemmli buffer and run on a 5-20% SDS-polyacrylamide gradient gel.
Gels were treated with Amplify (Amersham Corp., Arlington Heights, IL)
and dried forfluorography. Gels were exposed for 7-30 d to film (X-GMAT
AR; Eastman Kodak Co., Rochester, NY) at -80°C. Densitometry was
performed onavideodensitometer fromBio-Rad Laboratories (model 620;
Richmond, CA).
MicrosomePreparation andExtraction with Urea,
Salt, or7lritonX-114
Mitotic or interphase cells were labeled and washed once withhomogeniza-
tion buffer (0.25 M sucrose in 10 mM Tris-HCI, pH 7.4, and 1 mM mag-
nesium acetate). The cell pellet was diluted with 4 vol of homogenization
buffer andthe cells brokenby 10 passes through a ball bearing homogenizer
with a clearance of 0.008 in. (Balch and Rothman, 1985). Postnuclear su-
pernatantswereprepared by centrifugationat 800g for 5 min at4°C. These
were then diluted with 3-4 vol of 1 mM Tris-HCI, pH 8.0, 1 mM EDTA
(TE buffer), and centrifuged in a table-top ultracentrifuge (model TL-100,
TLA 100.3 rotor; Beckman Instruments, Inc., Palo Alto, CA) at 100,000
rpm for 30 min at 4°C. The microsomes were either prepared directly for
gel electrophoresis or treated as follows. To treat membranes with urea or
high salt the microsomes were resuspended in homogenization buffer con-
taining either urea or KCI and incubated for 30 min on ice. The treated
membranes were separated into a pellet and supernatant fraction by cen-
trifugation in an SW 50.1 rotor (Beckman Instruments, Inc.) for 1 h at
100,000 g. Samples were then prepared for gel electrophoresis as described
above. Microsomes were treated with 1% Triton X-114 essentially as de-
scribedby Bordier(1981) andequal volumeswereloadedfor electrophoresis.
Protease ReatmentofMembrane Fractions
post-nuclear supernatants from 3H-palmitate-labeled cells were incubated
for 15 min at 37°C with 1, 5, or 50 Ag/ml ofproteinase K, or 2 or 10 pg/ml
of trypsin, which had been pretreated with 1 mM PMSF, in the presence
or absence of 0.5% Triton X-100. Reactions were stopped by transfer to ice
and the addition of PMSF to a final concentration of4 mM. The proteins
were then precipitated as described above and analyzed by SDS-PAGE.
Galactosyltransferase activity was measured by the method of Bretz and
Satubli (1977) on replicate incubations from unlabeled cells.
SubcellularFractionation
Post-nuclear supernatants were prepared, as described above, from 3H-
palmitate-labeled and unlabeled mitotic or interphase cells. 2 ml of the
post-nuclear supernatant was layered on a sucrose gradient consisting of
50% (1 ml), 45% (1.5 ml), and2 ml eachof40, 35, 30, 25, and 15 % sucrose
(wt/wt) in TE buffer and centrifuged at 25,000 rpm for 15 h in an SW 28.1
rotor at 4°C. Fractions ofx+1.2 ml were collected from the bottom. Tb ana-
lyze the 3H-palmitate labeled fractions, 0.5 ml of each fraction was diluted
to 3 ml with TE buffer and pelleted at 40,000 rpm in an SW 50.1 rotor for
1 h. The proteins were then precipitated and processed for electrophoresis
and fluorography as described above. The unlabeled fractions were ana-
lyzed for the following marker activities: galactosyl transferase for the
Golgi apparatus (Bretz and Staubli, 1977); choline phosphotransferase for
136the ER (Percy etal ., 1991) ; alkalinephosphodiesterase for theplasma mem-
brane (Storrie and Madden, 1990);,6-hexosaminidase for lysosomes (Stor-
rie and Madden, 1990) ; and succinic dehydrogenase formitochondria (Pen-
nington, 1961) . The cis-Golgi compartment was assayed by Western
blotting with 1251-protein A using an antibody to p58, a protein which is
a marker for this compartment (Saraste et al ., 1987) . The proteins in each
fraction were precipitated and separated on 846 SDS-PAGE and transferred
to Immobilon P in 10mM CAPS, pH 11, containing 10% methanol . Mem-
branes were blocked with 5 % nonfat dry milk in TS (20mM Tris, pH 7.5,
150mM NaCl) and 1% Tween-20 and then incubated for 2 h at 25°C with
a 1:1,000 dilution of an antibody to p58 followed by ' 251-proteinA for 1 h .
ClevelandGels
Partial proteolysis was performed by the method ofCleveland et al . (1977)
using a kit from Promega Biotec (Madison, WI) with 0.05 pg alkalinepro-
tease and 0.25 jig endoproteinase Lys-C exactly as described by the
manufacturer. Alkaline protease cleaves at the carboxylic sides ofaromatic
and neutral amino acids . Endoproteinase Lys-C cleaves at the carboxylic
side oflysine . Purified microsomes from mitotic or BFA-treated cells were
first separatedby 10% SDS-PAGE. The piece ofthegel containing p62 was
excised by comparisonto a fluorograph ofa portion ofthe gel that had been
treated with Amplify, dried, andexposed to film . Thesegel pieceswerethen
layered on a 10-20% gradient gel, overlaid with the protease solution and
electrophoresed . Gels were then treated as above and fluorographed.
Results
p62Is Acylated in Mitotic Cells
When mitotic and interphase cells were labeled with 3H-
palmitate the patterns of acylated proteins, resolved by elec-
trophoresis, were different. The most striking difference was
theappearanceofa 62-kD protein in mitotic cells, which was
not apparent in interphase cells (Fig. 1) . The acylation ofthis
protein was increased from 5- to 10-fold during mitosis. This
was subsequently shown to be a protein (see below) and so
will be referred to as p62 . Mitotic cells were prepared using
the microtubule inhibitor nocodazole, which is also required
during the labeling period to ensure that the cells remain mi-
totic. The appearance ofp62 was not caused by the presence
ofthis microtubule inhibitor because treatment of interphase
cells for up to 3 h with nocodazole had no effect on acylation .
To show that existing and not newly synthesized p62 was be-
ing acylated, cells were labeled with 3H-pahnitate in the
Figure 1. p62 is palmitoylated
in mitotic but not interphase
cells. Interphase and mitotic
cells were preincubated for 20
min with or without 10 p,glml
cycloheximide (CHX) before
labeling for 90 min with 3H-
palmitate. Note the presence
of p62 (arrowhead) in mitotic
but not interphase cells . The
molecular weight marker pro-
teins for this and succeeding
figures are : phosphorylase b
(97 kD) ; bovine serum albu-
min (66 kD) ; ovalbumin (43
kD) ; carbonic anhydrase (31
kD) ; soy bean trypsin inhibi-
tor (21 kD) ; and lysozyme
(14 kD) .
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Figure 2 . p62 is no longer palmitoylated in cells that have exited
mitosis . Interphase cells (Int), mitotic cells (Mit), and G1 cells
were labeled with 3H-palmitate for 60 min . GI cells were gener-
ated by incubating mitotic cells in the absence of nocodazole for
0 or 30 min before adding the 3H-pahnitate. The mitotic index in-
dicated on the figure was determined at the end of the labeling
period .
presence of cycloheximide at a concentration that inhibited
protein synthesis >98% . The pattern ofacylated proteins in
mitotic cells was completely unchanged when protein syn-
thesis was inhibited (Fig. 1) . The amount of labeling in inter-
phase cells was markedly reduced by treatment with cyclo-
heximide but the pattern remained essentially the same with
one exception . A protein at -35 kD disappeared . This pro-
tein was also sensitive to digestion with glycopeptidase F
(unpublished observations) which indicates that it is a glyco-
protein and might therefore be expected to be sensitive to in-
hibitors ofprotein synthesis . A similar reduction in the label-
ing of proteins with 3H-palmitate in the presence of protein
synthesis inhibitors has been reported by several other inves-
tigators (Magee and Courtneidge, 1985 ; McIlhinney et al .,
1985 ; Olson and Spizz, 1986) . In mitotic cells protein syn-
thesis is already inhibited (Buell and Fahey, 1969), which
may explain the relative lack of effect of cycloheximide on
fatty acylation in those cells .
The acylation of p62 is tightly associated with the cell cy-
cle . To show this, mitotic cells were allowed to exit mitosis
and enter Gl by removing nocodazole and then pulse labeled
with 3H-pahnitate as they did so . As shown in Fig . 2, p62
was not labeled if 3H-palmitate was added to cells 30 min
after removal of nocodazole (for 1 h), a point at whichmost
of the cells were in late telophase or early Gl . If cells were
labeled (for 1 h) immediately after the nocodazole was re-
moved, the amount of label on p62 was also substantially re-
duced . The mitotic index for the cells at this intermediate
137Figure 3. p62 is found on the cytoplasmic side of membranes . (A)
Post-nuclear supernatants from 3H-palmitate labeled cells were
treated with the indicated concentrations of proteinaseK or trypsin
in the presence or absence of detergent as described in Materials
and Methods, analyzed by SDS-PAGE, and fluorographed . (B)
Replicate incubations from unlabeled cells were analyzed for galac-
tosyltransferase activity . Note that most of the 3H-palmitate la-
beled proteins, including p62, are digested in the absence of deter-
gent . m, no detergent ; m, +Triton X-100 .
stage was 25% . In pulse-chase experiments p62 lost label
only very slowly (data not shown), much slower than the
time needed for the cells to exit mitosis and for p62 to cease
being a substrate for acylation . 3H-palmitate is incorpo-
rated into all cellular lipids and without the ability to block
reincorporation of the label into the protein of interest,
definitive pulse-chase experiments are not possible . The la-
bel on p62 was removed by treatment with hydroxylamine at
pH 7.0 indicating that the palmitate is attached to the protein
by a thioester linkage (data not shown) .
p62 Is 7FghtlyAssociated with Membranes
Post-nuclear supernatants were prepared from 3H-palmi-
tate-labeled cells and fractionated to yield membranes and
cytosol . All of the palmitoylated proteins, in both interphase
and mitotic cells, were found in the membrane fraction and
not in the cytosol (data not shown) . p62 was sensitive to di-
gestion with proteases (Fig. 3 A) in contrast to the luminally
disposed Golgi marker, galactosyl transferase, which was
sensitive only in the presence of Triton X-100 (Fig . 3 B) .
This shows that at leastpart of the p62 (that carrying the pal-
mitoyl group) is exposed on the cytoplasmic face of mem-
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branes . All of the palmitoylated proteins appear to be sensi-
tive to protease digestion in the absence of detergent, which
is consistent with previous reports that the majority of the
acylated proteins are cytoplasmically oriented (Wilcox and
Olson, 1987) . p62 was tightly associated with membranes
since it is not removed byKCl up to 1 M (Fig . 4B) . Sodium
carbonate treatment atpH 11 removed the 3H-palmitate label
and therefore could not be tested . p62 was removed from
membranes by urea but only by concentrations in excess of
4 M (Fig . 4 A) .
The detergent Triton X-114 can be used to separate inte-
gral membrane proteins from soluble proteins by phase sepa-
ration although this characterization is not always definitive .
When membranes are treated with Triton X-114 all the
palmitoylated proteins except two, p62 and an ti88-kD pro-
tein, remained in the detergent phase (Fig. 4 C) . In Triton
X-114, p62 appears to separate into two bands . The lower
molecular weight band is found in the aqueous phase and a
higher molecular weight band remains in the detergent
phase . It is not yet known if these are different proteins or
if they representthe same protein, perhaps with an additional
posttranslational modification . p62 also does not appear to
be N-glycosylated because treatment with glycopeptidase F
had no effect on its molecular weight (data not shown) .
p62 Cofractionates with aMarkerforthecis-Golgi
To determine the subcellular location of acylated p62, post-
nuclear supernatants from interphase and mitoticCHO cells
were fractionated on sucrose gradients . p62 was distributed
throughout fractions 1-9, but peaked in fractions 4-7 (Fig .
5, A and C) . We cannot yet determine whether the nonacy-
lated form has the same distribution . Fractions from the su-
crose gradient were also blotted using an antibody to p58,
a marker for the cis-Golgi (Fig . 5 B) . p62 and p58 cofrac-
tionate exactly (Fig . 5 C), which is consistent with the inter-
pretation that p62 is contained in this compartment . Fig . 6
shows the distribution ofvarious marker enzymes on the su-
crose gradients . The acylated form of p62 does not cofrac-
tionate with markers for lysosomes, mitochondria, ER, or
the plasma membrane . p62 also does not cofractionate with
the trans-Golgi marker, galactosyl transferase. Interestingly,
whereas the ER marker, choline phosphotransferase, and the
Golgi marker, galactosyl transferase, are completely separa-
ble in interphase cells (data not shown), in mitotic cells, the
ER shifts in density to comigrate with the galactosyl trans-
ferase peak (see Fig . 6) . This is possibly because of the loss
ofribosomes (Zeligs and Wollman, 1979) since protein syn-
thesis is'inhibited during mitosis .
p62 Is Labeledin Interphase Cells Tlreated with BFA
The fungal metabolite, BFA, rapidly and reversibly blocks
transport ofproteins out ofthe ER and also results in the dra-
matic disassembly of the Golgi apparatus by the resorption
ofmost ofthe Golgimembranes into theER (Misumi et al .,
1986 ; Lippincott-Schwartz et al ., 1989, 1990) . When inter-
phase CHO cells were labeled with 3H-palmitate in the
presence of BFA there was a striking and selective increase
in the labeling of a component with the same molecular
weight as p62 (Fig. 7 A) . Labeling did not require preincuba-
tion with the drug and was not altered by pretreatment ofthe
cells with cycloheximide (Fig . 7 B) . BFA treatment does
138Figure 4. p62 can be removed by urea and Triton X-114 but not by salt. Microsomes, prepared from mitotic cells labeled for 60 min with
3H-palmitate were resuspended in the indicated concentrations of urea (A) or KC1(B) and incubated on ice for 30 min before centrifuga-
tion at 400,000 g for 30 min to yield a membrane pellet (P) and supernatant (S) fraction. The proteins were precipitated and separated
on 10% SDS-polyacrylamide gels. (C) Microsomes were extracted with Triton X-114 and separated into a supernatant (S) and a detergent
(D) phase. Equal volumes were precipitated and the proteins separated on a 5-20% SDS-polyacrylamide gel . p62 is marked with an
arrowhead .
seem to reduce the labeling of most ofthe other proteins but
only p62 labeling is increased . Partial proteolysis of p62
from mitotic cells and interphase cells treated with BFA
confirmed their identity (Fig . 8) . Digestion with two differ-
ent enzymes generated the same 3H-pahnitate labeled frag-
ments from p62 isolated from either mitotic or BFA-treated
cells . Alkaline protease digestion yielded three major frag-
ments with approximate mol wt of 43,000, 34,000, and
21,000 and several minor fragments . Digestion with en-
doprotease lys-C generated a 21- and a 31-kD fragment al-
though the digestion did not go to completion . The digestion
with endoprotease lys-C may be inefficient because of the
long destaining period before the band was excised and run
in the second dimension . This was necessary because a por-
tion of the gel had to be dried and fluorographed before the
appropriate band could be excised (see Materials and
Methods) . This result also demonstrates that the palmitoy-
lated component is a protein .
BFA had no effect on the level of p62 labeling in mitotic
cells (Fig . 7 A) showing that the effects are not additive and
suggesting it mimics the mitotic mechanism . The effect of
BFA was very rapid, with p62 appearing within 5-10 min of
addition of the drug and reaching a maximum at -30 min
(Fig . 9) . This rapid appearance of label on p62 is consistent
with the time course of the effects of BFA on CHO cells,
where a morphologically identifiable Golgi apparatus was
shown to disappear within 15 min after the addition of the
drug (Doms et al., 1989) . The effect ofBFA on the appear-
ance ofp62 was reversible (Fig . 10, A and B) . In the presence
ofBFA labeling ofp62 was very prominent, and if cells were
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first pretreated with BFA for 15 min but the drug was re-
moved during the labeling period, some labeling of p62 was
apparent . If, however, label was added 15 min after the
pretreatment then little if any labeled p62 was seen .
The redistribution of Golgi enzymes to the endoplasmic
reticulum caused by BFA is prevented by nocodazole (Lip-
pincott-Schwartz et al ., 1990) . Pretreatment of interphase
cells for 1 h with 20 wg/ml of nocodazole, before labeling
in the presence ofboth BFA and nocodazole, did not prevent
the acylation of p62 (data not shown) . This would indicate
that p62 is not becoming acylated because it has been redis-
tributed to the ER as a result oftreatment withBFA . Incuba-
tion at 16°C also blocks retrograde transport and, therefore,
the disassembly ofthe Golgi apparatus, butp62 still becomes
acylated in the presence of BFA at this temperature . These
treatments do not, however, prevent the dissociation of the
110-kD protein, which is the earliest (within 30 s) observable
effect of BFA treatment in cells (Donaldson et al ., 1991) .
This would imply that acylation ofp62 occurs after the disso-
ciation of the 110-kD protein but before the actual disassem-
bly of the Golgi apparatus.
The effect ofBFA on p62 labeling is not limited to CHO
15B cells . Fig. 11 shows thatCHO wild-type, normal rat kid-
ney, A431, HeLa, and BHK cells respond in the same way.
A protein of the same molecular weight as p62became heav-
ily labeled with 3H-palmitate in these cell types .
Ap62 Is also Labeled in Interphase Cells ?heated with
other Inhibitors ofIntracellular Thansport
BFA inhibits intracellular transport and causes the disassem-
139Figure 5. p62 cofractionates
with p58, a marker for the
cis-Golgi . (A) Fractionsfrom
'H-palmitate labeled cells were
diluted andfractionated to ob-
tain membranes as described
in Materials and Methods .
The proteins were precipitated
andseparatedby 5-20% SDS-
PAGE andfluorographed . (B)
The same fractions in A were
separated on 8% SDS-PAGE
and Western blotted with an
antibody to p58 as described
in Materials and Methods .
The membranes were dried
and exposed at -80°C to Ko-
dak X-GMAT AR film for
24h. (C) Densitometry ofthe
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bly of the Golgi apparatus and both effects also occurduring
mitosis (Burke et al., 1982; Hiller and Weber, 1982), al-
though during mitosis there is no evidence of redistribution
of Golgi enzymes to the ER (Lucocq et al., 1989). As de-
scribed above, acylation ofp62 occurs even when disassem-
bly of the Golgi apparatus is prevented by pretreatment with
nocodazole. To further support the hypothesis that the in-
crease in palmitoylation of p62 is related to an effect on
transport rather than due to the disassembly of the Golgi ap-
paratus, several other inhibitors of intracellular transport
were tested for their ability to alterthe pattern of fatty acyla-
tion. CCCP has been used to inhibit transport of proteins at
a stage between the ER and the Golgi apparatus (see Burk-
hardt and Argon, 1989, for references) . A 62-kD protein be-
comes palmitoylated in interphase cells treated with CCCP








from mitotic cells, whichwere
either labeled for 90 min with
3H-palmitate or unlabeled, and
fractionated on sucrose gradi-
ents as described in Materials
and Methods. The amount of
p62 in each fraction was deter-
mined by densitometry and
plotted against markers for
mitochondria, the plasma mem-
brane, lysosomes, the ER, and
the trans- and cis-Golgi ap-
paratus. p62 cofractionates
exactly only with p58, the




prevented if cellsare labeled in medium containing glucose.
Preincubation with CCCP is not required and the labeling
pattern is the same in the presence or absence of BFA.
Monensin also inhibits intracellular transport of many pro-
teins to the cell surface and they accumulate in the Golgiap-
paratus (Tartakoff, 1983; Griffiths et al., 1983). As shown
in Fig. 12 B, a protein with the same molecular weight as
p62 becomes acylated in cells treated with monensin. As in
BFAtreated and mitotic cells, labeling was not sensitive to
cycloheximide (data not shown). Aluminum fluoride has
been used both in intact cells and in cell-free systems to
block transport at a step which is dependent on a GTR
binding protein (Melançon et al ., 1987; Orci et al., 1989) .
Fig. 12 B compares the labeling of p62 in interphase cells
with BFA, monensin, or aluminum fluoride-treated cells.
Neither aluminum fluoride nor monensin were as efficient atFigure 7 . A p62 protein is palmitoylated in interphase cells treated with BFA . (A) Mitotic or interphase cells were labeled with 3H-
palmitate for 60 min in the presence or absence of 6 jig/ml of brefeldin A (BFA) . One sample was pre-incubated with the drug for 15
min before labeling. (B) Interphase cells were preincubated in the presence or absence of 10 ug/ml of cycloheximide for 20 min before
labeling for 60 min with 3H-pahnitate in the presence or absence of6 gg/ml ofBFA . For cycloheximide-treated cells the drug was present
both before and during the labeling period .
increasing the label on p62 as BFA . If, however, cells were
preincubated with monensin for 2 h, the amount oflabel on
p62 reached the level in BFAtreated cells .
Discussion
A number of cellular processes requiring vesicular transport
are inhibited during mitosis making this a powerful tool for
studying the transport process . Since fatty acylation is re-
quired during intra-Golgi transport we examined the palmi-
toylation of proteins in interphase and mitotic cells . In this
mannerwe have identified a protein, p62, as a potential can-
didate for the palmitoylation target required in transport .
Several lines of evidence point to the involvement of p62 in
intracellular transport . First, there is a good correlation be-
tween the level of p62 and the stage in the cell cycle. p62 can
be labeled by 3H-palmitate in mitotic cells, a state in which
intracellular transport is inhibited, but not in interphase or
Gl cells where transport has resumed .
Second, p62 can be labeled in interphase cells treated with
inhibitors of intracellular transport . BFA blocks the move-
ment ofproteins to the Golgi apparatus probably by disrupt-
ing the formation of the putative Golgi vesicle coat (Orci
et al ., 1991) . The retrograde pathway continues, however,
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which results in the redistribution of at least some of the
Golgi enzymes back to theER, and this results in the disas-
sembly of the Golgi apparatus (Lippincott-Schwartz et al .,
1990) . The effect ofBFA on the fatty acylation ofp62 is strik-
ing and very rapid and is consistent with the time required
forBFA to exertits effects on the cell . Golgi reassembly after
removal of BFA takes -30 min, again similar to the time
course forp62 to cease being a major substrate for palmitoy-
lation. Also, the effect of BFA on palmitoylation is not
related to the redistribution of p62 or another protein to a
different compartment since the increase in the palmitoyla-
tion of this protein is seen even when redistribution is in-
hibited with nocodazole. Several cell types were treated with
BFA and in each case there is a dramatic increase in the level
of acylation ofa N62-kD protein . Monensin inhibits trans-
port ofmany proteins at the level of the Golgi stack (Tar-
takoff, 1983 ; Griffiths et al ., 1983) . CCCP inhibits transport
primarily between the ER and the Golgi stack (Fries and
Rothman, 1980 ; Kabcenell and Atkinson, 1985 ; Argon and
Milstein, 1984) butmay inhibit at a later stage as well (Burk-
hardt and Argon, 1989), and aluminum fluoride, which is
thought to interact with GTP binding proteins required in
transport, acts at both the ER to Golgi stage (Beckers and
Balch, 1989) and within the Golgi stack itself (Melançon et
142Figure 8. p62 from mitotic cells is the same protein as p62 in inter-
phase cells treated with BFA . p62 from mitotic and BFA-treated
cells was subjected to Cleveland analysis to determine if it is the
same protein . Alkaline protease treatment generated three major
3H-palmitate-labeled fragments with a relative molecular mass of
-43,000, 34,000, and 21,000 in both cases . Endoproteinase Lys-C
digestion generated21AD and 31-kD acylated fragments although
the digestion did not go to completion .
al ., 1987) . In all three cases, the acylation of p62 is in-
creased .
Third, the acylated form of p62 is tightly associated with
the cytoplasmic surface ofmembranes which cofractionate
on sucrose step gradients with the cis-Golgi . p58 was origi-
nally described as a marker for the cis-Golgi (Saraste et al .,
1987) . However, recent evidence suggests that it may be
more accurate to refer to this region of the cell as the cis-
Golgi network, which consists then ofthe intermediate com-
partment between the ER and the Golgi and the cis-most
cistema of the Golgi apparatus . One of the functions of
this compartment appears to be the recycling of proteins
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Figure 10 . The effect of BFA is reversible . Interphase cells were
preincubated for 15 min with 6 jig/ml ofBFA and then labeled for
60 min with 3H-palmitate either in the continued presence ofBFA
or after its removal by extensive washing . Label was added either
0, 15, or 30 min after the removal ofBFA, as indicated in the figure.
(A) Fluorogram . (B) Quantitation of the label in the p62 protein
in each lane .
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Figure 9. BFA causes rapid palmitoylation
ofp62 . Interphase cells were prelabeled for
30 min with 3H-palmitate and labeling was
continued in the presence or absence of
61g/ml BFA for up to 60 min.back to theER since the KDEL receptor is also localized to
this regionofthe cell (Lewis and Pelham, 1990) . Lippincott-
Schwartz et al . (1990) showed thatthe intermediate compart-
ment, in contrast to the Golgi apparatus, remains as a dis-
tinct organelle in the presence of BFA . The localization of
p62 in this intermediate compartment or cis-Golgi network
is also consistent with our finding that p62 is not redis-
tributed to a different compartment uponBFA treatment . By
our method we only detect the acylated form of p62 and do
notknow the distribution of the deacylated form. There are
several possibilities . First, this is the true distribution of p62
and the bulkofthe protein is associated with the intermediate
compartment. Second, p62may be associated with all the or-
ganelles throughout the transport pathway but the portion
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that is in the intermediate compartment becomes acylated
because the enzyme is located there . Or third, p62 moves
throughout the pathway but when transport is inhibited dur-
ing mitosis it accumulates in this compartment either be-
cause it is acylated or because some downstream event is
blocked . The exact subcellular localization of p62 will there-
fore require the production of an antibody.
p62 is labeled in cells treated with cycloheximide, indicat-
ing that the protein exists in an acylated and a deacylated
form . The changes in the labeling of p62 can best be ex-
plained by an acylation/deacylation cycle. In the steady state,
in interphase cells, the deacylated form predominates but in-
hibition of transport either during mitosis or in the presence
of transport inhibitors causes the acylated form to accumu-
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Figure 11. BFA stimulates the acylation of
a p62 protein in several types ofcells . Each
cell type was grown in 60-mm dishes and
labeled with 3H-palmitate for 60min in the
presence or absence of 6 ug/nd BFA.
Figure 12 . Other inhibitors of intracellular
transport also stimulate the acylation of a
p62 protein . (A) Interphase cells were la-
beled for 60 min with 3H-palmitate in glu-
cose free DME in the absence (INT) or
presence of 6 pg/ml BFA or 10 pM CCCP.
Where indicated, the cells were prein-
cubated for 30 min with CCCP and then la-
beled in the presence or absence of BFA.
(B) Cells were labeled as inA with no addi-
tions (INT) or with 6 jg/ml BFA, 10 AM
monensin or aluminum fluoride (3 mM
NaF ; 50,uM AIC13 ) without preincubation .late. This could be due to a direct effect on the acylase or
by inhibiting the deacylase. Either would provide a means of
identifying the enzyme(s) involved. p62 may becomeacylated
as a mechanism to inhibit its function or because it is not
being consumed. This might be an indirect effect caused by
inhibition of a reaction further downstream which in turn
prevents p62 from discharging its palmitoyl group in the nor-
mal manner. If rapid turnover of the acyl group is occurring,
it could be due to the uncoupling of p62 from a regulatory
subunit. In the presence of radioactivepalmitate, label would
accumulate under these conditions. These possibilities can-
not yet be distinguished.
The function of p62 is unknown but it could be a compo-
nent of the transport mechanism which is thought to be
shared by all vesicle-mediated steps from the ER to the
trans-Golgi network. This is supported by the fact that inhib-
itors that act at different steps of intracellular transport have
the common effect of increasing the level of acylation of p62
and the effects of mixing inhibitors are not additive. Trans-
port is thought to be initiated by the formation ofa coat com-
plex (Waters et al ., 1991), which must bind to Golgi mem-
branes yet cannot do so by binding to the cytoplasmic tails
of transported proteins, as does the clathrin coat (Pearse,
1988), because transport is nonselective. One possible solu-
tion, which arises from the known dependence of budding
on added palmitoyl-CoA, is that the coat could attach by re-
versible addition of palmitoyl groups to one or more of the
coat components. It is therefore ofinterest that one ofthe ma-
jor proteins of the coat complex, &-COP, has almost the same
molecular weight as p62 . If true, this would mean that this
coat protein remains bound to membranes during mitosis
and treatment with BFA, a result at variance with the known
behavior of one of the other coat proteins, fl-COP (Donald-
son et al., 1990). It is, however, possible that the coat disas-
sembles under these conditions and the different components
behave differently. It has recently been demonstrated that
BFA prevents the assembly of the nonclathrin-coated vesi-
cles in a cell-free system (Orci et al., 1991) and the authors
speculate that a possible target for BFA is either a subunit
of the coat itself or the binding site in the membrane. Ifp62
were the target, irreversible acylation may explain inhibition
of transport.
Both budding and fusion show a dependence for added
palmitoyl-CoA and there is no reason to believe that the
palmitoyl requirement is different for each step. Another
suggestion for the role ofp62 might therefore be as an acylat-
ing enzyme or the acyl donor providing palmitoyl groups for
both steps of vesicle mediated transport. This is consistent
with its localization in the cis-Golgi network, which is also
the site for acylation of viral glycoproteins (Bonatti et al.,
1989) . The acylated enzyme may accumulate because a
blockin transport prevents it from discharging its acyl group.
If p62 is an acylating enzyme that may explain the general
reduction in the acylation of most proteins upon treatment
of cells with BFA. Finally, it has been suggested that
palmitoylation can alter the interaction of a protein with
GTP-binding proteins (for references see McIlhinney, 1990).
This is interesting since GTP-binding proteins are thought to
be required for transport (Beckers and Balch, 1989; Melan-
çon et al., 1987) and guanine nucleotides can also modulate
the effects of BFA on cells (Donaldson et al ., 1991) . Perhaps
theacylation ofp62 affects its interaction with a GTP binding
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protein which is required in the transport pathway. Sugges-
tive though these arguments might be, the role played by p62
must await its purification and further biochemical and
genetic characterization.
The observed increase in palmitoylation ofp62 during mi-
tosis is dramatic and readily apparent even in total cell ex-
tracts. Ours is the first demonstration that the acylation of a
protein can be altered during the cell cycle. Although the
functional consequences of protein palmitoylation have not
been defined, the data suggest that fatty acylation may play
an important role in regulating cellular processes during mi-
tosis.
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